BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25407913)

  • 1. Fluorescence-based monitoring of PAD4 activity via a pro-fluorescence substrate analog.
    Sabulski MJ; Fura JM; Pires MM
    J Vis Exp; 2014 Nov; (93):e52114. PubMed ID: 25407913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facile fluorescence-based detection of PAD4-mediated citrullination.
    Wildeman E; Pires MM
    Chembiochem; 2013 May; 14(8):963-7. PubMed ID: 23640867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAD2 Activity Monitored via a Fluorescent Substrate Analog.
    Sabulski MJ; Wang Y; Pires MM
    Chem Biol Drug Des; 2015 Oct; 86(4):599-605. PubMed ID: 25643806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization.
    Luo Y; Arita K; Bhatia M; Knuckley B; Lee YH; Stallcup MR; Sato M; Thompson PR
    Biochemistry; 2006 Oct; 45(39):11727-36. PubMed ID: 17002273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4.
    Arita K; Shimizu T; Hashimoto H; Hidaka Y; Yamada M; Sato M
    Proc Natl Acad Sci U S A; 2006 Apr; 103(14):5291-6. PubMed ID: 16567635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fluopol-ABPP HTS assay to identify PAD inhibitors.
    Knuckley B; Jones JE; Bachovchin DA; Slack J; Causey CP; Brown SJ; Rosen H; Cravatt BF; Thompson PR
    Chem Commun (Camb); 2010 Oct; 46(38):7175-7. PubMed ID: 20740228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and screening of a haloacetamidine containing library to identify PAD4 selective inhibitors.
    Jones JE; Slack JL; Fang P; Zhang X; Subramanian V; Causey CP; Coonrod SA; Guo M; Thompson PR
    ACS Chem Biol; 2012 Jan; 7(1):160-5. PubMed ID: 22004374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autocitrullination of PAD4 does not alter its enzymatic activity: In vitro and in silico studies.
    Liu X; Wichapong K; Lamers S; Reutelingsperger CPM; Nicolaes GAF
    Int J Biochem Cell Biol; 2021 May; 134():105938. PubMed ID: 33529715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic characterization of protein arginine deiminase 4: a transcriptional corepressor implicated in the onset and progression of rheumatoid arthritis.
    Kearney PL; Bhatia M; Jones NG; Yuan L; Glascock MC; Catchings KL; Yamada M; Thompson PR
    Biochemistry; 2005 Aug; 44(31):10570-82. PubMed ID: 16060666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supramolecular Chemistry-Assisted Electrochemical Method for the Assay of Endogenous Peptidylarginine Deiminases Activities.
    Zhao J; Yang L; Tang Y; Yang Y; Yin Y
    ACS Appl Mater Interfaces; 2017 Jan; 9(1):152-158. PubMed ID: 27958698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiling Protein Arginine Deiminase 4 (PAD4): a novel screen to identify PAD4 inhibitors.
    Knuckley B; Luo Y; Thompson PR
    Bioorg Med Chem; 2008 Jan; 16(2):739-45. PubMed ID: 17964793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine Retinal Citrullination Declines With Age and is Mainly Dependent on Peptidyl Arginine Deiminase 4 (PAD4).
    Hollingsworth TJ; Radic MZ; Beranova-Giorgianni S; Giorgianni F; Wang Y; Iannaccone A
    Invest Ophthalmol Vis Sci; 2018 Aug; 59(10):3808-3815. PubMed ID: 30073354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a highly sensitive fluorescence probe for peptidyl arginine deiminase (PAD) activity.
    Kunieda K; Kawaguchi M; Ieda N; Nakagawa H
    Bioorg Med Chem Lett; 2019 Apr; 29(7):923-928. PubMed ID: 30773431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAD4: pathophysiology, current therapeutics and future perspective in rheumatoid arthritis.
    Koushik S; Joshi N; Nagaraju S; Mahmood S; Mudeenahally K; Padmavathy R; Jegatheesan SK; Mullangi R; Rajagopal S
    Expert Opin Ther Targets; 2017 Apr; 21(4):433-447. PubMed ID: 28281906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional role of dimerization of human peptidylarginine deiminase 4 (PAD4).
    Liu YL; Chiang YH; Liu GY; Hung HC
    PLoS One; 2011; 6(6):e21314. PubMed ID: 21731701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and use of clickable activity based protein profiling agents for protein arginine deiminase 4.
    Slack JL; Causey CP; Luo Y; Thompson PR
    ACS Chem Biol; 2011 May; 6(5):466-76. PubMed ID: 21265574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity-based protein profiling reagents for protein arginine deiminase 4 (PAD4): synthesis and in vitro evaluation of a fluorescently labeled probe.
    Luo Y; Knuckley B; Bhatia M; Pellechia PJ; Thompson PR
    J Am Chem Soc; 2006 Nov; 128(45):14468-9. PubMed ID: 17090024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autodeimination of protein arginine deiminase 4 alters protein-protein interactions but not activity.
    Slack JL; Jones LE; Bhatia MM; Thompson PR
    Biochemistry; 2011 May; 50(19):3997-4010. PubMed ID: 21466234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theoretical study of the mechanism of protein arginine deiminase 4 (PAD4) inhibition by F-amidine.
    Li D; Liu C; Lin J
    J Mol Graph Model; 2015 Feb; 55():25-32. PubMed ID: 25424656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a new class of inhibitors for the protein arginine deiminase type 4 (PAD4) by structure-based virtual screening.
    Teo CY; Shave S; Chor AL; Salleh AB; Rahman MB; Walkinshaw MD; Tejo BA
    BMC Bioinformatics; 2012; 13 Suppl 17(Suppl 17):S4. PubMed ID: 23282142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.